Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Julphar
Federal Trade Commission
AstraZeneca
Merck
Boehringer Ingelheim
Covington
Healthtrust

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070031

« Back to Dashboard

NDA 070031 describes SODIUM NITROPRUSSIDE, which is a drug marketed by Abraxis Pharm, Akorn, Amneal Pharms Co, Amphastar Pharms Inc, Baxter Hlthcare, Micro Labs, Mylan Labs Ltd, Namigen Llc, Nexus Pharms, and Teva Parenteral, and is included in ten NDAs. It is available from six suppliers. Additional details are available on the SODIUM NITROPRUSSIDE profile page.

The generic ingredient in SODIUM NITROPRUSSIDE is sodium nitroprusside. There are one thousand four hundred and twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
Summary for 070031
Tradename:SODIUM NITROPRUSSIDE
Applicant:Abraxis Pharm
Ingredient:sodium nitroprusside
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/VIAL
Approval Date:Jan 17, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fish and Richardson
McKesson
Boehringer Ingelheim
US Department of Justice
Johnson and Johnson
Julphar
Healthtrust
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.